<?xml version="1.0" encoding="UTF-8"?>
<p>We appear to be entering a new era in which several important emerging, reemerging, and stable infectious diseases are becoming better controlled (e.g., hepatitis B, rabies, 
 <italic>Haemophilus influenzae</italic> type B, and even to some extent HIV/AIDS). However, our success in stopping the many new emerging diseases that will inevitably appear is not assured. We have many tools in our armamentarium, including preparedness plans and stockpiles of drugs and vaccines. But each new disease brings unique challenges, forcing us to continually adapt to ever-shifting threats 
 <xref rid="ppat.1003467-Fauci1" ref-type="bibr">[1]</xref>â€“
 <xref rid="ppat.1003467-World1" ref-type="bibr">[10]</xref>, 
 <xref rid="ppat.1003467-Kilpatrick1" ref-type="bibr">[23]</xref>. The battle against emerging infectious diseases is a continual process; winning does not mean stamping out every last disease, but rather getting out ahead of the next one.
</p>
